C-Further to advance its first two bespoke paediatric cancer therapeutics in collaboration with leading global academic and industry investigators Selected programmes to potentially address multiple ...

Application supported by Phase 3 data reinforcing teclistamab regimens as a potential standard of care after at least one prior therapy1 ...

Green Thumb Industries Inc. is upgraded to Buy due to strong free cash flow and a robust balance sheet. Learn more about GTBIF stock here.

Voluntary exercise reshapes gut microbiota and tryptophan metabolism, with consequences for the hippocampus, the ...

Los Angeles Pacific University reports that as industries rapidly evolve due to technological innovation, economic disruption, and longer career lifespans, a growing number of working professionals ...

The FDA assigned a PDUFA target action date of December 22, 2026 - - The NDA is based on positive data from a successful clinical program demonstrating favorable safety and blood pressure reduction ...

Disney is developing a live-action Peter Pan spin-off centered on tiny fairy Tinker Bell, to launch on Disney+. Tink, as the project is titled, will feature an updated version of the classic fairy ...

Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025In post hoc analysis of the pivotal RESILIENT ...

ZORYVE cream 0.05% was safe and well-tolerated, with efficacy that was maintained and improved over time up to 56 weeks of treatmentChildren ages ...

Study data from patients with relapsed or refractory gynecologic cancers signals the potential of LYMPHIR to augment immune checkpoint inhibitor efficacy Topline data ...

A Dunedin man with a history of sexual abuse against children has been jailed indefinitely with a minimum prison term of seven years and three months for b ...